Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction SPIRRIT-HFpEF

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-517448-79-00

Enrollment

2000

Registered

2024-09-23

Start date

2017-11-23

Completion date

Unknown

Last updated

2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure with preserved ejection fraction

Brief summary

Incidence rate for total heart failure (HF) hospitalizations or cardiovascular (CV) death.

Interventions

DRUGSPIRONOLACTONE

DRUGEPLERENONE

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Incidence rate for total heart failure (HF) hospitalizations or cardiovascular (CV) death.	—

Countries

Sweden

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026